Live Feed

Delayed 3m

Insider · SEC · FDA · Financials

Signed out · 3-min delay · Sign up for real-time

PR18:00:00·6h·Health Care·
$MANE
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
Conference call will take place on Monday, October 19, 2026, at 8:00 am ET Veradermics, Incorporated (NYSE:MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced it will host an investor call and live webcast on Monday, October 19, 2026, at 8:00 am ET to review results from Part A of its randomized, double-blind, placebo-controlled registration-directed Phase 3 clinical trial (Study ‘304’) evaluating VDPHL01, a proprietary, extended-release oral minoxidil formulation, in over 500 males with mild-to-moderate pattern hair loss. Webcast Details: The event and the accompanying slides will be
PR16:00:00·8h·Consumer Discretionary·
$ETD
“Where Are the Numbers?” Doug Bergeron Calls on Ethan Allen to Release First Quarter Results Before November 4 Board Vote
Company Has Yet to Announce an Earnings Release Date, Departing from a Decade of Consistent Disclosure Practice Raises Serious Questions About Board Credibility Following Inaccurate Financial Claims and Mischaracterizations of Mr. Bergeron’s Nominees and Plan to Restore Growth Warns Shareholders Not to Be Fooled by Selective Financial Claims and Repeated Growth Promises That Obscure Two Decades of Decline Doug Bergeron, a significant shareholder of Ethan Allen Interiors Inc. ("Ethan Allen" or the "Company") (NYSE:ETD) with beneficial ownership, collectively with his affiliates and associates, of approximately 5.2% of Ethan Allen’s outstanding common stock, today called on Ethan Allen
PR22:30:00·2d·Energy·
$BLDP
Ballard Announces Q3 2026 Results Conference Call
VANCOUVER, BC, Oct. 16, 2026 /CNW/ -- Ballard Power Systems (NASDAQ:BLDP) (TSX:BLDP) will hold a conference call on Monday November 16th, 2026 at 8:00 a.m. Pacific Time (10:00 a.m. Eastern Time) to review third quarter 2026 operating results. The live call can be accessed by dialing +1-833-821-2814 (Canada/US toll free). Alternatively, a live webcast can be accessed through a link on Ballard's homepage (www.ballard.com), in the 'Latest News' section or by clicking here: Q3 Webcast. Following the call, a link to the webcast will be available in the 'Investor Hub' area of the 'Investors' section of Ballard's website (www.ballard.
INSIDER21:57:56·2d·Industrials·
$ASPI
SEC Form 4 filed by ASP Isotopes Inc.
4 - ASP Isotopes Inc. (0001921865) (Issuer)
INSIDER21:56:48·2d·Technology·
$SKLZ
SEC Form 4 filed by Skillz Inc.
4 - Firy Inc. (0001801661) (Issuer)
INSIDER21:56:20·2d·Technology·
$SKLZ
SEC Form 4 filed by Skillz Inc.
4 - Firy Inc. (0001801661) (Issuer)
SEC21:52:26·2d·Finance·
$HTH
Amendment: SEC Form SCHEDULE 13D/A filed by Hilltop Holdings Inc.
SCHEDULE 13D/A - Hilltop Holdings Inc. (0001265131) (Subject)
INSIDER21:45:15·2d·Industrials·
$EVTL
SEC Form 4 filed by Vertical Aerospace Ltd.
4 - Vertical Aerospace Ltd. (0001867102) (Issuer)
INSIDER21:42:41·2d·Finance·
$WYFI
SEC Form 4 filed by WhiteFiber Inc.
4 - WhiteFiber, Inc. (0002042022) (Issuer)
INSIDER21:37:37·2d·Finance·
$WYFI
SEC Form 4 filed by WhiteFiber Inc.
4 - WhiteFiber, Inc. (0002042022) (Issuer)
INSIDER21:36:50·2d·Finance·
$WYFI
SEC Form 4 filed by WhiteFiber Inc.
4 - WhiteFiber, Inc. (0002042022) (Issuer)
INSIDER21:35:08·2d·Health Care·
$NTRA
SEC Form 4 filed by Natera Inc.
4 - Natera, Inc. (0001604821) (Issuer)
SEC21:21:15·2d·Health Care·
$ALXO
Amendment: SEC Form SCHEDULE 13D/A filed by ALX Oncology Holdings Inc.
SCHEDULE 13D/A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Subject)
INSIDER21:20:01·2d·Consumer Discretionary·
$PEW
SEC Form 4 filed by GrabAGun Digital Holdings Inc.
4 - GrabAGun Digital Holdings Inc. (0002051380) (Issuer)
INSIDER21:20:20·2d·Consumer Discretionary·
$PEW
SEC Form 4 filed by GrabAGun Digital Holdings Inc.
4 - GrabAGun Digital Holdings Inc. (0002051380) (Issuer)
INSIDER21:01:05·2d·Health Care·
$MBRX
SEC Form 4 filed by Moleculin Biotech Inc.
4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
INSIDER21:00:43·2d·Health Care·
$MBRX
SEC Form 4 filed by Moleculin Biotech Inc.
4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
INSIDER21:00:18·2d·Health Care·
$MBRX
SEC Form 4 filed by Moleculin Biotech Inc.
4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
SEC20:53:30·2d·Consumer Discretionary·
$CCO
Amendment: SEC Form SCHEDULE 13D/A filed by Clear Channel Outdoor Holdings Inc.
SCHEDULE 13D/A - Clear Channel Outdoor Holdings, Inc. (0001334978) (Subject)
INSIDER20:48:51·2d·Consumer Discretionary·
$CCO
SEC Form 4 filed by Clear Channel Outdoor Holdings Inc.
4 - Clear Channel Outdoor Holdings, Inc. (0001334978) (Issuer)